Here are five recent news updates on GI/endoscopy companies.
Allergan, a Botox maker, accepted a $66 billion takeover bid from pharmaceutical company Actavis. Actavis offered $219 per share in cash and stock, and its shares rose 1.7 percent to $247.94.
Actavis successfully completed its tender offer to purchase all outstanding shares of Durata Therapeutics. Actavis offered to purchase all outstanding shares of Durata for $23 per share in cash or approximately $675 million total.
Johnson & Johnson is seeking an excess of $5 billion in damages from Boston Scientific related to a decade-old bidding war over device company Guidant, according to a Reuters report.
Cantel Medical, the parent company of Medivators, promoted Jorgen Hansen from executive vice president and COO to president and COO.
Salix Pharmaceuticals executive vice president William P. Forbes sold 11,079 shares of the company's stock for a total of $1.05 million, according to a Mideast Times report.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.